Skip to main content

Table 1 Treatment information on study animals in the 10% imidacloprid + 2.5% moxidectin (Advantage Multi®) and nontreated groups

From: Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi® for Dogs) for the prevention of heartworm disease and infection all month long

Treatment group

Gender

Dog ID#

Study day

Body weight (pounds)

Dose (mL)

Group 1:

10% imidacloprid + 2.5% moxidectin

Female

1531603

−30

29.0

2.5

Female

1531805

−30

16.6

1.0

Female

1531806

−30

18.6

1.0

Female

1531903

−30

19.0

1.0

Male

1531502

−30

21.0

2.5

Male

1531801

−30

25.4

2.5

Male

1531802

−30

24.2

2.5

Male

1531901

−30

30.6

2.5

Group 2:

no treatment

Female

1531503

−30

17.6

0

Female

1531702

−30

25.2

0

Female

1531706

−30

25.0

0

Female

1531803

−30

19.6

0

Female

1531804

−30

17.8

0

Female

1532203

−30

19.0

0

Male

1531501

−30

32.4

0

Male

1532101

−30

30.4

0